BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 12371988)

  • 1. Risk factors for late kidney allograft failure.
    Ponticelli C; Villa M; Cesana B; Montagnino G; Tarantino A
    Kidney Int; 2002 Nov; 62(5):1848-54. PubMed ID: 12371988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A; Woo KT
    Clin Transpl; 1999; ():189-97. PubMed ID: 11038637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Living-donor kidney transplantation in the cyclosporine era].
    Campise M; Tarantino A; Berardinelli L; Finazzi S; Montagnino G; Rossini G; Scalamogna M; Cesana B; Ponticelli C
    G Ital Nefrol; 2002; 19(1):49-54. PubMed ID: 12165946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term and long-term survival of kidney allograft: cure model analysis.
    Mirzaee M; Azmandian J; Zeraati H; Mahmoodi M; Mohammad K; Etminan A; Dehghani Firouzabadi MH; Habibzade S; Haghparast M
    Iran J Kidney Dis; 2014 May; 8(3):225-30. PubMed ID: 24878946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recipient-related risk factors for graft failure and death in elderly kidney transplant recipients.
    Lai X; Chen G; Qiu J; Wang C; Chen L
    PLoS One; 2014; 9(11):e112938. PubMed ID: 25389964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of chronic allograft nephropathy and subsequent modifications of immunosuppressive therapy on late graft outcomes in renal transplantation.
    Montagnino G; Banfi G; Campise MR; Passerini P; Aroldi A; Cesana BM; Ponticelli C
    Nephrol Dial Transplant; 2004 Oct; 19(10):2622-9. PubMed ID: 15316096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late calcineurin inhibitor withdrawal as a strategy to prevent graft loss in patients with suboptimal kidney transplant function.
    Weir MR; Blahut S; Drachenburg C; Young C; Papademitriou J; Klassen DK; Cangro CB; Bartlett ST; Fink JC
    Am J Nephrol; 2004; 24(4):379-86. PubMed ID: 15237243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Late complications following renal transplantation].
    Bemelman FJ; ten Berge RJ
    Ned Tijdschr Geneeskd; 2008 Jun; 152(23):1317-21. PubMed ID: 18661857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation.
    Woo YM; McLean D; Kavanagh D; Ward L; Aitken S; Miller GJ; Egan P; Hughes K; Clark L; Carswell K; Morris ST; Northridge DB; Rodger RS; Jardine AG
    J Nephrol; 2002; 15(4):380-6. PubMed ID: 12243367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients.
    Kuo PC; Luikart H; Busse-Henry S; Hunt SA; Valantine HA; Stinson EB; Oyer PE; Scandling JD; Alfrey EJ; Dafoe DC
    Clin Transplant; 1995 Apr; 9(2):92-7. PubMed ID: 7599409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why does kidney allograft fail? A long-term single-center experience.
    Alarrayed S; El-Agroudy A; Al-Arrayed A; Ghareeb S; Farid E; Garadah T; Abdulla S
    Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):818-24. PubMed ID: 21743242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of transplant outcomes in peritoneal and hemodialysis patients.
    Snyder JJ; Kasiske BL; Gilbertson DT; Collins AJ
    Kidney Int; 2002 Oct; 62(4):1423-30. PubMed ID: 12234315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable cyclosporine exposure: a risk factor for chronic allograft nephropathy and graft loss?
    He X; Johnston A
    Transplant Proc; 2004 Jun; 36(5):1321-6. PubMed ID: 15251323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival.
    Moroni G; Longhi S; Quaglini S; Gallelli B; Banfi G; Montagnino G; Messa P
    Nephrol Dial Transplant; 2013 May; 28(5):1305-14. PubMed ID: 23229925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causes of late transplant failure in cyclosporine-treated kidney allograft recipients.
    Moroni G; Binda V; Quaglini S; Sacchi L; Raffiotta F; Cosa F; Montagnino G; Favi E; Messa P; Ponticelli C
    Clin Exp Nephrol; 2019 Aug; 23(8):1076-1086. PubMed ID: 31016431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.